Seegene Unveils STAgora and CURECA at ESCMID Global 2026

Seegene, a global total solution provider for molecular diagnostics, announced on April 20 that it participated in the ESCMID Global 2026·ESCMID (European Society of Clinical Microbiology and Infectious Diseases), held in Munich, Germany from April 17 to 21 (local time). At the event, Seegene unveiled advanced models of its real-time test data analysis and statistics platform STAgora™ (STAgora) and its unmanned PCR automation system CURECA™ (CURECA), presenting strategies focused on automation and data-driven diagnostics.

From the opening of the exhibition, officials from various countries visited the Seegene booth. Visitors observed the automated PCR testing process at the CURECA station, asking questions, while at the STAgora station, they experienced simulations firsthand and expressed surprise at the platform’s intuitive structure.

At this year’s conference, Seegene highlighted the message "From Numbers to Insights," emphasizing the value of transforming data into insights by combining automation-based testing infrastructure with its data analysis and statistics platform.

Baek Youngseok, Executive Vice President and Head of New Business at Seegene, explained, "STAgora is a data analysis and statistics platform designed to connect PCR test data generated worldwide in real time, providing intuitive insights into infection trends. By allowing medical professionals to compare their individual test results with regional and global infection statistics, the platform enables more multidimensional insights."

Visitors experienced the data-driven interpretation model through real-time dashboards showing comparative statistics for single and multiplex syndromic PCR tests, infection trends by period and region, changes in pathogen-specific positivity rates, and patterns of co-infection. In particular, the structure that allows test results to be viewed alongside regional outbreak information attracted significant attention at the venue.

The advanced model of the unmanned PCR automation system CURECA was also exhibited, allowing visitors to receive explanations about the equipment’s structure and module composition and to follow the automated workflow from preprocessing and nucleic acid extraction to amplification and result analysis. Many attendees showed keen interest in the internal structure and processing methods of the equipment, asking questions about its practical applicability in real-world laboratories.

Shin Daeho, Executive Vice President and Head of Global Business at Seegene, stated, "There was strong interest at the conference in the real-world applications and data analysis features of STAgora. We plan to gradually expand platform adoption by increasing pilot validations and collaborations with global medical institutions."

During the conference, Seegene also held discussions with global partners and representatives from major testing institutions about the introduction and validation of STAgora and CURECA. Focusing especially on Europe, Seegene organized sessions to explain product and platform implementation strategies to representatives from medical and testing institutions such as C-lab, thereby strengthening on-site communication. Through these efforts, Seegene aims to deepen discussions on the adoption of STAgora and CURECA, and will gradually pursue the discovery of real-world application cases and the review of academic utilization possibilities.

This content was produced with the assistance of AI translation services.